Sinovac Biotech Ltd. - Product Pipeline Review - 2016

  • ID: 3960475
  • Company Profile
  • 32 pages
  • Global Markets Direct
  • Sinovac Biotech Ltd
1 of 5

FEATURED COMPANIES

  • Addex Therapeutics Ltd
  • Denovo Biopharma, LLC
  • Domain Therapeutics SA
  • Eli Lilly and Company
  • Medgenics, Inc.
  • Prexton Therapeutics SA
  • MORE
Sinovac Biotech Ltd. - Product Pipeline Review - 2016

The report ‘Sinovac Biotech Ltd. - Product Pipeline Review - 2016’, provides an overview of the Sinovac Biotech Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sinovac Biotech Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note - : Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Sinovac Biotech Ltd.
- The report provides overview of Sinovac Biotech Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Sinovac Biotech Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Sinovac Biotech Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Sinovac Biotech Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Sinovac Biotech Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Sinovac Biotech Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Addex Therapeutics Ltd
  • Denovo Biopharma, LLC
  • Domain Therapeutics SA
  • Eli Lilly and Company
  • Medgenics, Inc.
  • Prexton Therapeutics SA
  • MORE
Introduction

Sinovac Biotech Ltd. Snapshot

Sinovac Biotech Ltd. Overview

Key Facts

Sinovac Biotech Ltd. - Research and Development Overview

Key Therapeutic Areas

Sinovac Biotech Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Sinovac Biotech Ltd. - Pipeline Products Glance

Sinovac Biotech Ltd. - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

Sinovac Biotech Ltd. - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Sinovac Biotech Ltd. - Drug Profiles

(measles + mumps + rubella) vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

chickenpox vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

coxsackievirus [serotype A16] vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

diphtheria + pertussis(acellular) + tetanus vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

haemophilus influenzae B vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

hepatitis A + hepatitis B vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

hepatitis B vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

influenza [strain A/H7N9] vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

polio vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

rabies vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

rotavirus vaccine - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Sinovac Biotech Ltd. - Pipeline Analysis

Sinovac Biotech Ltd. - Pipeline Products by Molecule Type

Sinovac Biotech Ltd. - Dormant Projects

Sinovac Biotech Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

List of Tables

Sinovac Biotech Ltd., Key Facts

Sinovac Biotech Ltd. - Pipeline by Indication, 2016

Sinovac Biotech Ltd. - Pipeline by Stage of Development, 2016

Sinovac Biotech Ltd. - Monotherapy Products in Pipeline, 2016

Sinovac Biotech Ltd. - Combination Treatment Modalities in Pipeline, 2016

Sinovac Biotech Ltd. - Partnered Products in Pipeline, 2016

Sinovac Biotech Ltd. - Partnered Products/ Combination Treatment Modalities, 2016

Sinovac Biotech Ltd. - Phase I, 2016

Sinovac Biotech Ltd. - IND/CTA Filed, 2016

Sinovac Biotech Ltd. - Preclinical, 2016

Sinovac Biotech Ltd. - Pipeline by Molecule Type, 2016

Sinovac Biotech Ltd. - Dormant Developmental Projects,2016

Sinovac Biotech Ltd., Subsidiaries

List of Figures

Sinovac Biotech Ltd. - Pipeline by Top 10 Indication, 2016

Sinovac Biotech Ltd. - Pipeline by Stage of Development, 2016

Sinovac Biotech Ltd. - Monotherapy Products in Pipeline, 2016

Sinovac Biotech Ltd. - Combination Treatment Modalities in Pipeline, 2016

Sinovac Biotech Ltd. - Partnered Products in Pipeline, 2016

Sinovac Biotech Ltd. - Pipeline by Molecule Type, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Addex Therapeutics Ltd
- Denovo Biopharma, LLC
- Domain Therapeutics SA
- Eli Lilly and Company
- Medgenics, Inc.
- Prexton Therapeutics SA
- Taisho Pharmaceutical Holdings Co., Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll